05/20/2026
Today on International Clinical Trials Day, we recognize and celebrate the people who make research and progress possible within the Fabry disease community and across the wider rare disease space.
To every patient, adult or pediatric, who has participated in a clinical trial, shared their experience, traveled to appointments, completed rigorous and often invasive testing, or faced uncertainty in hopes of helping future generations, we THANK YOU! YOUR courage, trust, sacrifice, and commitment are what moves science forward.
We also recognize the caregivers and family members who support participants every step of the way. Behind every trial participant is often a support system helping manage schedules, transportation, emotional stress, and daily responsibilities that come with living with a rare disease.
Thank you to the researchers, clinicians, study coordinators, and industry professionals dedicated to developing safer, more effective treatments and improving the lives of those impacted by Fabry. Progress only happens through collaboration and the push for innovation.
As we celebrate the progress that has been made and the treatments that have been developed, we must not forget the vital need to integrate the patient voice into every stage of the drug development process. Patients and caregivers provide critical insight into real-world challenges, quality of life concerns, and barriers to participation that might otherwise be overlooked. This is especially important in underserved and historically underrepresented communities, where access, trust, education, financial burden, transportation, language, and healthcare disparities can all impact participation in research.
Today and every day, we must remember that clinical trials are not only about endpoints, biomarkers, and what’s measured in a lab. They are about the PEOPLE who give so much of themselves to make them happen.
